3Kelling C,Steffen D,Topliff C,et al.Comparative virulence of isolates of bovine viral diarrhea virus type 2 in experimentally inoculated six to nine month-old calves[J].Am J Vet Res,2002,63:1379-1384.
5Fairbanks K,Schnakel J,Chase CC.Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge[J].Vet Ther,2003,4(1):24-34.
6Hamers C,Couvreur B,Dehan P,et al.Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge[J].Vet Rec,2003,153(8):236-240.
7Dean H,Hunsaker D,Bailey D,et al.Prevention of persistent infection in calves by vaccination of dams with noncytpathic type-1 modified love bovine viral diarrhea virus prior to breeding[J].Am J Vet Res,2003,64:530-537.
8Fairbanks KK,Rinehart CL,Ohnesorge WC,et al.Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine[J].J Am Vet Med Assoc,2004,225(12):1898-1904.
9Kovacs F,Magyar T,Rinehart C,et al.The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection[J].Vet Microbiol,2003,96(2):117-131.
10Frey H,Eicken K,Grummer B,et al.Foetal protection against bovine viral diarrhea virus[J].J Vet Med B,2002,49:489-493.
